Picture of BioAffinity Technologies logo

BIAF BioAffinity Technologies Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareMicro Cap

Annual cashflow statement for BioAffinity Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUS/APROSPECTUS/A10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-7.27-6.33-8.15-7.94
Depreciation
Non-Cash Items4.563.643.960.749
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.4830.6330.1140.901
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-2.21-2.05-4.07-6.04
Capital Expenditures-0.0030-0.22-0.023
Purchase of Fixed Assets
Other Investing Cash Flow Items-2.19
Acquisition of Business
Cash from Investing Activities-0.0030-0.22-2.21
Financing Cash Flow Items0-0.181-0.056
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.723.3314.3-0.345
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.4951.2810.1-8.59